Friday, July 31, 2026

It’s Almost Shark Week! South Korea Warns of Increased Shark Activity Along Its East Coast

The frequency of large shark species appearing...

AITRICS Achieves MDSAP Certification: What This Means for Global Medical Device Standards

AITRICS gains MDSAP certification, enhancing its global market entry and demonstrating compliance with international quality standards.

North Korea’s 3rd Training Session for City and County Party Secretaries: Key Insights and Outcomes

North Korea's 3rd training session for city and county party secretaries focused on local development and implementing the Party's agenda.

Tag: clinical trials

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Penetrium: The Next Breakthrough in Cancer Immunotherapy Starting Phase 2 Trials in the U.S.

Penetrium BioScience launches a Phase 2 clinical trial for Penetrium, targeting tumor microenvironments to enhance cancer immunotherapy.

U.S. pharmaceutical companies’ China clinical trial security probe to conclude this week… Could biotech rivalry intensify?

A U.S. investigation into pharmaceutical trials in China may reshape global biotech strategies, impacting South Korean firms.

Shaperon Secures South Korean Patent for Pulmonary Fibrosis Drug Candidate NuPulin

Shaperon secures a South Korean patent for NuPulin, an oral drug for idiopathic pulmonary fibrosis, showing promising preclinical results.

AI-Powered Antibody Drug Development: Samsung Biologics and Protina’s Game-Changing License Agreement

Samsung Bioepis and Protina sign a licensing agreement to develop AI-designed antibody drugs, aiming for candidates by 2027.

ABL Bio to Launch Global Phase 3 Trial of ABL111 in December, Targeting First-Line Gastric Cancer Treatment

ABL Bio will begin global Phase 3 trials for its dual antibody gastric cancer treatment 'ABL111' this December after FDA discussions.

China’s Fosun Pharma invests $27.5 million in AriBio, boosting optimism for Korean Alzheimer’s drug

Fosun Pharma invests $27.5 million in South Korea's AriBio, boosting its Alzheimer’s drug development and global commercialization efforts.

K-Bio shifts focus to clinical data as key trial readouts stack up in second half

Korea's biotech sector shifts focus to clinical data in H2 2023, with key results from leading companies expected to drive investor sentiment.

SK Chemicals and J2H Biotech Partner for Breakthrough MASH Treatment: What You Need to Know

SK Chemicals partners with J2H Biotech to develop J2H-1702, a treatment for metabolic-associated steatotic liver disease, enhancing drug pipeline.

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

LegoChem expands options beyond early ADC licensing into late-stage clinical development

LegoChem Biosciences secures funding to advance ADC therapies into late-stage trials, enhancing strategic flexibility in biotech.

GCCL Strengthens Global Clinical Trial Role: What This Means for Asia’s Biotech Industry?

GCCL aims to expand internationally as a central lab for clinical trials, enhancing services and leveraging competitive advantages.

Supply Chains, M&A and AI: As China Closes In, K-Bio Faces a Critical Window of Opportunity [BIO USA]

Korea's biotech industry faces challenges and opportunities amid global restructuring, emphasizing AI and support for startups at BIO USA 2026.

How Samsung’s Galaxy Watch and Alcedis are Revolutionizing Clinical Research with Real-World Data

Samsung Electronics partners with Alcedis to use Galaxy Watch data for drug development, enhancing clinical trials with wearable tech.

CT-P72/ABP-102: The Next Big Breakthrough in HER2 Cancer Treatment?

Celltrion's CT-P72/ABP-102 shows strong efficacy against HER2 tumors, promising for treating various cancers with reduced toxicity.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.